Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Shampa Das

Professor Shampa Das
BSc, PhD

Research

Research grants

Fleming Fund Fellowship Fund

THE FLEMING FUND (UK)

February 2024 - December 2025

Expansion of assessment pharmacodynamics of flomoxef-fosfomycin and fosfomycin/amikacin combinations for neonatal sepsis using the HFIM

GARDP FOUNDATION (SWITZERLAND)

August 2022 - March 2024

Development of a new rabbit model to characterise antifungal drug resistance

FOOD AND DRUG ADMINISTATION (USA)

September 2023 - September 2026

Hit Compound to Potentiate the Activity of Amikacin for Acinetobacter baumannii (Chequerboard)

GARDP FOUNDATION (SWITZERLAND)

October 2023 - January 2024

Novel Gram-Negative Antibiotic Now (T7.2 & T7.4) (GNA NOW)

EUROPEAN COMMISSION

July 2019 - September 2026

Pharmacodynamics of Antimicrobial Combinations for Neonatal Sepsis in Low-To-Middle Income Countries

GARDP FOUNDATION (SWITZERLAND)

November 2018 - July 2021

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI)

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

April 2020 - March 2025

Assessment of the PKPD of BWC0977

BUGWORKS RESEARCH INDIA PVT. LTD. (INDIA)

September 2019 - January 2027

An evidence-based preclinical framework development antimicrobial therapeutics cystic fibrosis

CYSTIC FIBROSIS TRUST (UK)

October 2021 - March 2026

Pharmacokinetic-Pharmacodynamic assessment of BV100 in the hollow fibre infection model WP1

BIOVERSYS (SWITZERLAND)

April 2021 - June 2025

ANT3310 - Assessment of the pharmacodynamics of ANT3310 a serine beta-lactamase inhibitor

ANTABIO (FRANCE)

January 2020 - December 2020

AAI101 and Cefepime in Epithelial Lining Fluid and Plasma in Healthy Volunteers REC

ALLECRA THERAPEUTICS GMBH (GERMANY)

January 2018 - September 2022

Pharmacokinetic-Pharmacodynamic analyses of novel metallo-betalactmase inhibitors in multidrug resistant Gram negative infections

ANTABIO (FRANCE)

May 2018 - October 2019

Assessment of tebipenem in the hollow fibre

SPERO OPCO INC (USA)

August 2016 - July 2018

PK-PD analyses of cefepime and AAI101 against MDR enterobacteriaceae

ALLECRA THERAPEUTICS GMBH (GERMANY)

October 2017 - October 2018

Initial Management of Pleural infection: Aspiration versus Chest Tube (IMPACT) trial (IMPACT)

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

August 2024 - July 2029

CF- TRAILFINDER (CF- TRAILFINDER)

CYSTIC FIBROSIS TRUST (UK)

December 2024 - November 2029

Establishing Mass Spectrometry Imaging and in silico spatial modelling as methods of assessing the distribution and penetration of topical antimicrobials across the cornea

FIGHT FOR SIGHT (UK)

March 2025 - December 2026